![]()
|
|
||||||||
J. Biol. Chem., Vol. 277, Issue 24, 21499-21504, June 14, 2002
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
,From the Department of Molecular Microbiology and Immunology, Oregon Health & Science University, Portland, Oregon 97201
Received for publication, March 9, 2002, and in revised form, April 2, 2002
| |
ABSTRACT |
|---|
|
|
|---|
Purine nucleoside and nucleobase transporters are
of fundamental importance for Trypanosoma brucei and
related kinetoplastid parasites because these protozoa are not able to
synthesize purines de novo and must salvage the compounds
from their hosts. In the studies reported here, we have identified a
family of six clustered genes in T. brucei that encode
nucleoside/nucleobase transporters. These genes, TbNT2/927,
TbNT3, TbNT4, TbNT5,
TbNT6, and TbNT7, have predicted amino acid
sequences that show high identity to each other and to TbNT2, a P1 type
nucleoside transporter recently identified in our laboratory.
Expression in Xenopus laevis oocytes revealed that
TbNT2/927, TbNT5, TbNT6, and TbNT7 are high affinity adenosine/inosine
transporters with Km values of <5
µM. In addition, TbNT5, and to a limited degree TbNT6 and
TbNT7, also mediate the uptake of the nucleobase hypoxanthine.
Ribonuclease protection assays showed that mRNA from all of the six
members of this gene family are expressed in the bloodstream stage of the T. brucei life cycle but that TbNT2/927 and
TbNT5 mRNAs are also expressed in the insect stage of
the life cycle. These results demonstrate that T. brucei
expresses multiple purine transporters with distinct substrate
specificities and different patterns of expression during the parasite
life cycle.
African trypanosomes are of considerable medical and economic
importance because they cause a debilitating disease in humans (sleeping sickness) and livestock (nagana) throughout a large portion
of sub-Saharan Africa (1). These parasites have a digenetic life cycle,
with two main stages: the bloodstream form
(BF)1 that lives in the
bloodstream of its mammalian host and the procyclic form (PF) that
lives in the insect vector (tsetse fly). Purines are essential for the
growth, multiplication, and survival of these organisms because the
parasites are incapable of synthesizing the purine ring de
novo (2, 3). Furthermore, nucleoside/nucleobase transporters are
of considerable pharmacological importance, because both purine analogs
and non-purine analog drugs are taken up by some of these permeases,
and loss of permease function can lead to drug resistance (4, 5).
Two different nucleoside transport systems have been characterized in
intact Trypanosoma brucei cells. The P1 type system mediates
the uptake of purine nucleosides (adenosine, inosine, and guanosine)
and is detected in both BF and PF life cycle stages, and the P2 type
system mediates the uptake of adenosine and adenine, as well as several
anti-trypanosomal drugs, and is detected only in the BF (6, 7)
parasites. In addition, four nucleobase transport activities have also
been identified. H1, H2, and H3 mediate the transport of hypoxanthine,
guanine, and adenine (8, 9). H1 activity is found in PF, and H2 and H3
activities are found in BF. In addition, the U1 activity mediates the
transport of uracil in PFs (10). However, meticulous functional and
biochemical characterization of these transporters at the molecular
level is needed to understand the biological role of purine
transporters in survival and adaptation of T. brucei to
different environments during its life cycle and to provide information
about drug delivery and drug resistance phenotypes associated with
purine transporters (11).
Previously we cloned and characterized the T. brucei
nucleoside transporter 2 gene, TbNT2, which encodes a
P1 type transporter expressed only in the BFs (12). In this study we
demonstrate that TbNT2 is a member of a multigene family. In
the reference strain TREU 927 used for the T. brucei genome
project (parsun1.path.cam.ac.uk/index.html), this family encodes six
similar but distinct transporters, denominated TbNT2/927 to TbNT7 (the
designation TbNT2/927 is used to distinguish this gene from
the closely related but nonetheless distinct TbNT2 gene that
was derived originally from T. brucei strain EATRO 110 (12)). All of the family members are clustered together in chromosome number II and are separated by ~9-kb intergenic regions. Functional expression of TbNT2/927 through TbNT7 in
Xenopus oocytes revealed that TbNT2/927, TbNT5, TbNT6, and
TbNT7 transport purine nucleosides with similar affinities in the low
micromolar range. Of note, TbNT5, and to a lesser extent TbNT6 and
TbNT7, also show significant hypoxanthine transport activity. Moreover,
ribonuclease protection assays indicate that the mRNAs from all six
genes are expressed in BF parasites, but only TbNT2/927 and
TbNT5 mRNAs are expressed at detectable levels in both
BFs and PFs. Consequently, members of this nucleoside
transporter family are differentially regulated during the
parasite life cycle and mediate the uptake of purine nucleosides and in
some cases also the nucleobase hypoxanthine. The presence of several P1
type transporters with similar but distinct biochemical properties and
divergent regulation of expression suggests that the purine transport
process in T. brucei is much more complex than was assumed
on the basis of previous studies with whole parasites.
Chemicals--
[ Growth of Parasites and Isolation of Nucleic
Acids--
Procyclic forms of T. brucei strain TREU 927 (13) were grown at 26 °C in Cunningham's medium (14). The
bloodstream forms of T. brucei strain TREU 927 from frozen
stocks were grown in Wistar rats, and blood was collected through
exsanguination. BFs were separated from blood cells on a DE52 (Whatman)
anion exchange column as described (15). The nucleic acids were
purified from trypanosomes following established procedures (16), and
Southern blots were performed using standard protocols (16).
Cloning and Sequencing of TbNT Family Members--
An RPCI-93
BAC (library 93 made at Roswell Park Cancer Institute, School of
Medicine, Buffalo, NY) clone designated 36E18 (EMBL/GenBankTM accession number AC007866) containing the
TbNT family cluster was identified by a BLAST search (17) of
the T. brucei data base
(www2.ebi.ac.uk/blast2/parasites.html) using the TbNT2 amino acid
sequence (12) as a query sequence. To subclone each gene from the BAC
clone 36E18, 100 ng of BAC DNA was used as template for six independent
PCR amplifications. The oligonucleotide O1 (5'-GGGGTACCACCATGGCAATGCTTGGT-3'),
representing the first five identical amino acids of the
TbNT family including a KpnI restriction site
(underlined) and a consensus Kozak sequence (18) (italics), was used as
forward primer, and a specific oligonucleotide, representing the
complement of the sequence within the 3'-untranslated region of each
TbNT ORF, was used as reverse primer. PCR amplification was
performed using Pfu TurboTM polymerase
(Stratagene) following the manufacturer's instructions. Amplified DNA
fragments were subcloned using the Zero BluntTM TOPO PCR
cloning kit (Invitrogen). The clones were further characterized by
restriction mapping and sequencing of the entire ORF. Oligonucleotide synthesis and automatic sequencing were performed by the Core Facility
of the Department of Molecular Microbiology and Immunology at the
Oregon Health and Science University using a model 394 DNA/RNA
synthesizer (Applied Biosystems) and the ABI model 377 DNA sequencer
(PerkinElmer Life Sciences).
DNA and Deduced Amino Acid Sequence Analysis--
DNA and
deduced amino acid sequence analysis were performed by using the
MacVector software (Intelligenetics). Transmembrane segments were
predicted using the TMPRED software
(www.ch.embnet.org/software/TMPRED_form.html).
TbNT2/927 Gene Family Expression in Xenopus Oocytes--
The
TbNT2/927 gene family ORFs were subcloned into the
EcoRI site of the Xenopus expression vector pL2-5
(19), linearized, and in vitro transcribed with T7 RNA
polymerase (Invitrogen) in the presence of CAP analog (Amersham
Biosciences) as described previously (20). Stage V-VI
Xenopus oocytes were injected with 23 nl of cRNA (~10 ng),
incubated in ND96 buffer for 3 days at 16 °C as described (20), and
used for uptake assays.
Uptake Assays--
Xenopus oocytes injected with cRNA
or water as control were incubated for 3 days after injection. Prior to
the assay, the oocytes were incubated for 30 min in ND96 buffer at room
temperature. Uptake of [3H]adenosine,
[3H]inosine, [3H]guanosine,
[3H]hypoxanthine, [3H]guanine, and
[3H]adenine was assayed by incubating oocytes with
radiolabeled substrates for the indicated times, followed by three
quick washes in cold ND96 buffer, and the samples were prepared for
liquid scintillation counting as described previously (12). For each data point, the number of picomoles of labeled substrate transported were calculated and plotted as a function of incubation time. These
data were fitted to a straight line by a linear regression analysis
with CA-Cricket Graph III software (Computer Associates International
Inc.). To perform substrate saturation curves, cRNA-injected oocytes
were incubated for 60 min in the presence of different concentrations
of substrate at room temperature. Control experiments demonstrated that
the uptake of substrate was linear over 60 min over the range of
concentrations tested. The Km values were estimated
by fitting the substrate saturation curves to the Michaelis-Menten
equation by nonlinear regression using the KaleidaGraph program
(Synergy Software).
Ribonuclease Protection Assay--
To explore the expression of
the TbNT2/927 family members, a ribonuclease protection
assay was performed by using the RPA IIITM ribonuclease
protection assay kit (Ambion), following the protocols recommended by
the manufacturer. Briefly, 10 µg of total RNA from TREU 927 PF or BF
were hybridized against specific antisense 32P-labeled
riboprobes, generated by the MAXIscriptTM T7 in
vitro transcription kit (Ambion), representing the complement of
the sequence within the 3'-untranslated region of each TbNT ~150 bp downstream from the 3' end of each ORF. The TbNT2/927 Gene Family Encodes P1 Type Nucleoside Transporter
Isoforms--
Biochemical characterization of purine nucleoside
transport in intact T. brucei parasites indicated the
presence of P1 type transport that mediates the uptake of adenosine and
inosine in both PFs and BFs (6). In previous studies (12), we have
cloned a P1 type transporter gene from T. brucei strain
EATRO 110, called TbNT2, that is a high affinity
adenosine/inosine transporter whose RNA is detectable only in BFs.
Genomic Southern blots hybridized with the TbNT2 ORF
indicated the presence of a multigene family, raising the possibility
that some of these TbNT2-like genes might encode other P1
type transporters.
To clone TbNT2-like genes, we first BLAST searched the
T. brucei genome data base using the TbNT2 amino acid
sequence as a query, and six ORFs were identified. All of the six ORFs
were contained in the same RPCI-93 BAC clone 36E18, which contains a
genomic DNA insert from chromosome number II of T. brucei
strain TREU 927 (www.tigr.org/tdb/mdb/tbdb/progress.html), and the
predicted amino acid sequences showed high identity to TbNT2 (81-96%
identity). The gene that predicted a protein with the highest identity
(96%) to the original TbNT2 was designated TbNT2/927
(T. brucei nucleoside transporter 2/927). Moreover,
TbNT2/927 is the first gene in the array of the locus
according to the predicted transcription direction (Fig.
1). The other P1 type genes were
designated TbNT3 through TbNT7. All genes were
cloned using a PCR strategy and sequenced to determine the identity of
each one by comparing the DNA and predicted amino acid sequences with
those obtained from the T. brucei data base. In addition, we
identified five copies of an interspersed unrelated gene within the
TbNT array, encoding a putative isopenicillium-N-synthase
gene (INS in Fig. 1).
Gene multiplicity is a common feature in kinetoplastid protozoa (21),
and each gene often encodes the same protein (22). However, in some
examples, gene families encode similar but not identical proteins (23,
24). The six predicted TbNT proteins were very similar along the entire
amino acid sequences (Fig. 2), suggesting
that they are nucleoside transporter isoforms. Moreover, the predicted
topology indicated 11 TMDs for all six proteins, similar to the human
equilibrative nucleoside transporter 1 (ENT1), whose topology was
recently experimentally elucidated by Sundaram et al. (25).
The 11 TMDs shown in Fig. 2 are those predicted for TbNT2/927. The
overall comparison showed four regions of major divergence between the
six protein sequences. Those regions are limited to the extracellular
loops between TMD1 and TMD2, TMD5 and TMD6, and TMD7 and TMD8 and the
large intracellular loop between TMD6 and TMD7.
Functional Expression of TbNT2/927 through TbNT7 in Xenopus
Oocytes--
To identify the substrate specificity of the
TbNT2/927 family members, we tested the ability of oocytes
expressing TbNT2/927 through TbNT7 to mediate the
uptake of purine nucleosides. Initial experiments indicated that
TbNT2/927, TbNT5, TbNT6, and
TbNT7 cRNA-injected oocytes were able to transport
adenosine, inosine, and guanosine at significantly higher rates than
the control water-injected oocytes (Fig.
3A). However, TbNT3
and TbNT4 cRNA-injected oocytes did not mediate the uptake
of any purine nucleosides compared with the control water-injected
oocytes (data not shown). To characterize the affinity of these
transporters for adenosine and inosine, the Km
values were calculated from substrate saturation curves (Fig.
3B), revealing that TbNT2/927, TbNT5, TbNT6, and TbNT7 were
high affinity adenosine/inosine transporters (Table I) with Km values of
<5 µM.
To test for potential functional differences between the distinct
proteins, we also examined the ability of TbNT2/927 through TbNT7 to
mediate the transport of purine nucleobases. Interestingly TbNT5 cRNA-injected oocytes were able to mediate the uptake
of hypoxanthine at a significantly higher level than the control water-injected oocytes (Fig. 4).
Moreover, saturation curves for TbNT5 revealed a Km
value of 49.4 ± 13.3 µM (mean ± S.D., n = 3) for hypoxanthine. In contrast TbNT6 and
TbNT7 showed limited but still significant hypoxanthine transport
activity, whereas TbNT2/927, TbNT3, and TbNT4 did not show any ability
to transport this nucleobase. Additional experiments were conducted to
test the transport of guanine and adenine, but none of the six
permeases transported these purines (data not shown). In summary, there are clear differences in substrate specificity among members of the
TbNT2/927 family. TbNT2/927 is a purine nucleoside transporter, TbNT5,
TbNT6, and TbNT7 transport hypoxanthine in addition to the purine
nucleosides, and TbNT3 and TbNT4 have not exhibited any clear transport
activity for the substrates tested here including adenosine, inosine,
guanosine, xanthosine, adenine, hypoxanthine, guanine, xanthine,
cytosine, uracil, thymine, cytidine, thymidine, uridine,
S-adenosylmethionine, spermidine, putrescine, and
AMP.
In intact T. brucei parasites, transport of nucleosides (7)
and nucleobases (8) has been shown to be dependent upon the
transmembrane proton motive force, strongly suggesting that these
permeases are active proton symporters. Indeed, uptake of adenosine by
TbNT2/927, TbNT5, TbNT6, and
TbNT7 cRNA-injected oocytes was significantly inhibited by
carbonyl cyanide p-trifluoromethoxyphenylhydrazone or
2,4-dinitrophenol (data not shown), suggesting that the adenosine uptake by these permeases is coupled to proton translocation.
TbNT2/927 Gene Family Expression in the Life Cycle of T. brucei--
To explore the expression of each member of the
TbNT2/927 family in the two major life cycle stages of
T. brucei, a ribonuclease protection assay was performed
employing specific antisense 32P-labeled riboprobes from
the 3'-untranslated region of each gene. Ribonuclease protection assay
experiments revealed that RNA from all of the members of the family was
detected in the BFs (Fig. 5). In
addition, RNA from TbNT2/927 and TbNT5 was also
detected in the PFs. However, TbNT2/927 expression was
similar in both BF and PF life cycle stages, whereas TbNT5
expression was up-regulated in the BF stage. In T. brucei, purine nucleoside and nucleobase
transporters have been extensively studied at the biochemical level (6, 8, 9) and shown to play important roles in the biochemistry and
pharmacology of these parasites. More recently, studies at the
molecular level began with the cloning of the TbAT1 (P2 type nucleoside transporter) (26) and of the TbNT2 (a P1 type
nucleoside transporter) (12) genes. Thus, TbAT1 and TbNT2 function
correlated with many of the biochemical features of nucleoside
transport in intact parasites. However, the original TbNT2
gene (EATRO 110 strain) encoding a P1 type transporter was expressed
only in BF parasites, whereas P1 activity could be detected in both BFs
and PFs (6). These results, along with the observation of multiple fragments on genomic Southern blots that hybridized to a
TbNT2 probe (12), suggested that other P1 type transporters
were likely to exist. In this study, we report the functional
expression and characterization of the TbNT2/927 gene
family, four members of which encode high affinity adenosine, inosine,
guanosine transporters, placing them within the P1 type of nucleoside
transporters previously defined at the biochemical level (6, 12).
However, TbNT5, TbNT6, and TbNT7 were also able to mediate the uptake
of hypoxanthine, a nucleobase that plays a central role in the purine
salvage pathway of these parasites (3). This result is consistent with
previous observations that some other ENT family members, specifically TbAT1 (26), human ENT2 (27), and PfNT1 (28), are able to transport some
nucleobases, most often with substantially higher Km
values than for nucleosides.
It will be interesting to determine what specific molecular
determinants confer hypoxanthine transport function upon TbNT5, TbNT6,
and TbNT7. Examination of the multi-alignment (Fig. 2) reveals that
there are five amino acids (Val47, Lys48,
Lys52, Pro55, and Val78 in TbNT5)
that are conserved in these three permeases but that are different in
TbNT2/927, TbNT3, and TbNT4. The first four of these residues are
located in the extracellular loop between predicted TMD1 and TMD2, and
Val78 is located within predicted TMD2. It is possible that
some of these residues confer hypoxanthine transport capacity upon
TbNT5, TbNT6, and TbNT7.
It is noteworthy that we have not been able to identify any substrates
for TbNT3 or TbNT4 in the Xenopus oocytes expression system.
One possibility is that TbNT3 and TbNT4 are not functional transporters. Alternatively, the two permeases may transport some substrate that we have not tested. Compounds that we have examined as
potential substrates for TbNT3 and TbNT4 include purine nucleosides and
nucleobases, pyrimidine nucleosides and nucleobases,
S-adenosylmethionine, polyamines, and AMP, but none of these
solutes are substrates. We have also considered the possibility that
TbNT3 and TbNT4 could form functional hetero-oligomers. However,
coinjection of TbNT3 and TbNT4 cRNAs into oocytes
did not elicit any transport function for any of the compounds listed
above. Still another possible explanation for the failure of these
proteins to mediate purine transport is that they require for function
other subunits that are not present in the oocytes. The requirement for
multiple subunits has been observed for several amino acid
transporters (29).
There is ample precedent for the existence of multiple isoforms of
various transporters in both unicellular and multicellular eukaryotes
(30, 31). In multicellular organisms, distinct isoforms may be
expressed in different tissues where they subserve the physiological
needs of each cell type (32). The TbNT2/927 family encompasses six
permeases whose sequences are distinct but closely related. It is
possible that each permease has unique properties that collectively
promote the viability of the parasite in its natural environment. Thus,
examination of substrate specificity for each permease has revealed
differences that could in part explain the distinct roles of different
family members. Furthermore all six mRNAs are expressed in BF
parasites, but only TbNT2 and TbNT5 mRNAs are
also expressed in PF parasites. This observation raises the possibility
that different purine permeases could be differentially regulated to
accommodate the potentially distinct nucleoside composition of the
mammalian bloodstream and the tsetse fly gut. Finally, it is possible
that different members of this family are targeted to discrete
subcellular locations where they might subserve unique functions.
Ultimately, it will be important to define the potentially unique
biological roles of each member of the TbNT2/927 family.
A substantial amount of the T. brucei genome has been
sequenced as genome survey sequence clones
(www.sanger.ac.uk/Projects/T_brucei/), raising the likelihood that
many of the T. brucei genes encoding nucleoside or
nucleobase transporters that are members of the ENT family have been at
least partially sequenced and can be identified by BLAST searches.
Using such "data base mining" approaches, we have identified two
new ENT family members designated TbNT8 and TbNT9.2 There are multiple
TbNT8 genes arranged in a tandem cluster representing very
closely related ORFs, whereas TbNT9 appears to be a single copy gene. Functional expression of both of these genes in
Xenopus oocytes reveals transport activity for both
nucleobases and nucleosides. However, we cannot yet rule out the
possibility that other nucleoside/nucleobase transporters exist that
exhibit low homology to the currently identified permeases or that are
members of different transporter families.
![]()
INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES
![]()
MATERIALS AND METHODS
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES
-32P]dCTP (3000 Ci
mmol
1), [
-32P]UTP (800 Ci
mmol
1), [2,8,5'-3H]adenosine (54.4 Ci
mmol
1), and [2,8-3H]adenine (28.8 Ci
mmol
1) were purchased from PerkinElmer Life Sciences;
[2,8-3H]inosine (34 Ci mmol
1) and
[8-3H]guanine (15 Ci mmol
1) were purchased
from American Radiolabeled Chemicals Inc.; and [2,8-3H]hypoxanthine (24.5 Ci mmol
1) and
[8-3H]guanosine (5 Ci mmol
1) were purchased
from Movarek Biochemicals. All of the other chemicals were of the
highest commercial quality available.
-Tubulin
was used as a control gene that is expressed at similar levels in BFs
and PFs. After RNase A/T1 treatment and ethanol precipitation, protected RNA was resolved on 6% denaturing polyacrylamide gel and
detected by exposing the gel to x-ray film (Kodak OMAT-AR) or to a
PhosphorImager screen.
![]()
RESULTS
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES
![]()
View larger version (11K):
[in a new window]
Fig. 1.
Schematic representation of the
TbNT2/927 gene family in T. brucei
TREU 927 strain. The complete BAC 36E18 DNA sequence
containing the TbNT2/927 gene family cluster was retrieved
from the GenBankTM (accession number AC007866). The
arrows represent the TbNT ORFs, the black
boxes represent the isopenicillium synthase (INS)
homolog, the thick black lines indicate the intergenic
regions, and the diagnostic restriction enzyme sites are indicated. The
representation is not drawn to scale. In the numbering scheme employed,
TbNT7 is positioned to the left of
TbNT6. The reason for this nonsequential numbering is that
several ORFs were identified, named, and partially characterized before
the physical order of the ORFs had been determined by assembly of the
entire 36E18 BAC clone sequence.

View larger version (86K):
[in a new window]
Fig. 2.
Multi-alignment of the deduced amino acid
sequence of TbNT2/927, TbNT3, TbNT4, TbNT5, TbNT6, and TbNT7.
Alignment was performed using CLUSTALW (MacVector, Intelligenetics).
The spaces introduced to optimize the alignment are indicated by
periods. Labeled solid lines over the TbNT2/927
sequence indicate the predicted transmembrane domains
(www.ch.embnet.org/software/TMPRED_form.html)
for this protein. The numbers at the right
indicate the amino acid positions in each sequence.

View larger version (12K):
[in a new window]
Fig. 3.
Functional expression of cRNA in
Xenopus laevis oocytes. A, time course
for uptake of 0.5 µM [3H]adenosine
(Ado) by oocytes injected with TbNT5 cRNA
(closed circles) or by oocytes injected with water
(open circles) as control. For each time point, uptake
(pmol) into at least three oocytes was measured and
averaged; the error bars represent the standard deviations
of these values. B, substrate saturation curve for
[3H]adenosine in oocytes injected with TbNT5.
For each [3H]adenosine concentration, at least three
oocytes were incubated with the substrate for 60 min, and the
individual velocities were averaged; the error bars
represent the standard deviations of these values.
Km values for adenosine and inosine in TbNT2/927 through TbNT7
cRNA injected Xenopus oocyte

View larger version (32K):
[in a new window]
Fig. 4.
TbNT2/927 family shows differences in
substrate specificity. Uptake assays were performed for 60 min in
the presence of 0.5 µM [3H]adenosine
(empty bars) or 25 µM
[3H]hypoxanthine (filled bars) in
TbNT2/927 through TbNT7 cRNA-injected oocytes.
Each bar represents the average of at least three
independent measurements, and the error bars indicate the
standard deviations. The asterisks indicate values that are
significantly different (p < 0.02) from the control
water-injected oocytes as determined by the two-tailed Student
t test. Note that uptake of hypoxanthine in control
water-injected oocytes (2 ± 0.3 pmol oocyte
1
h
1) is considerably higher than uptake of adenosine
(0.22 ± 0.04 pmol oocyte
1 h
1).
-Tubulin riboprobe was
used as a control for an RNA that is expressed at similar levels in
both the BF and PF life cycle stages of T. brucei.
![]()
View larger version (14K):
[in a new window]
Fig. 5.
TbNT2/927 gene family is
differentially expressed during the life cycle of T. brucei. Fragments protected from RNase digestion by
specific antisense riboprobes were resolved in 6% acrylamide, 8 M urea gels and exposed to x-ray films or to a
PhosphorImager screen. BF lanes indicate protected fragments
using RNA from bloodstream form parasites, and PF lanes
indicate protected fragments using RNA from procyclic form parasites. A
control
-tubulin (
-tub) riboprobe was used to
demonstrate that similar amounts of PF and BF mRNA were present in
each sample.
![]()
DISCUSSION
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES
| |
FOOTNOTES |
|---|
* This work was supported by National Institutes of Health Grant AI 44138 (to S. M. L.).The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
To whom correspondence should be addressed: Dept. of Molecular
Microbiology and Immunology, Oregon Health & Science University, 3181 S.W. Sam Jackson Park Rd., L220, Portland, OR 97201-3098. Tel.:
503-494-7588; Fax: 503-494-6862; E-mail: sanchezm@ohsu.edu.
§ Recipient of the Burroughs Wellcome Fund Scholar Award in Molecular Parasitology.
Published, JBC Papers in Press, April 5, 2002, DOI 10.1074/jbc.M202319200
2 M. A. Sanchez, C. Henriques, M. van Ampting, and S. M. Landfear, unpublished data.
| |
ABBREVIATIONS |
|---|
The abbreviations used are: BF, bloodstream form; PF, procyclic form; ORF, open reading frame; ENT, equilibrative nucleoside transporter; TMD, transmembrane domain; BAC, bacterial artificial chromosome.
| |
REFERENCES |
|---|
|
|
|---|
| 1. | Boothroyd, J. C. (1985) Annu. Rev. Microbiol. 39, 475-502[CrossRef][Medline] [Order article via Infotrieve] |
| 2. | Hammond, D. J., and Gutteridge, W. E. (1984) Mol. Biochem. Parasitol. 13, 243-261[CrossRef][Medline] [Order article via Infotrieve] |
| 3. | Berens, R. L., Krug, E. C., and Marr, J. J. (1995) in Biochemistry and Molecular Biology of Parasites (Marr, J. J. , and Müller, M., eds) , pp. 89-117, Academic Press, New York |
| 4. | Baldwin, S. A., Mackey, J. R., Cass, C. E., and Young, J. D. (1999) Mol. Med. Today 5, 216-224[CrossRef][Medline] [Order article via Infotrieve] |
| 5. |
de Koning, H.,
and Jarvis, S. M.
(1999)
Mol. Pharmacol.
56,
1162-1170 |
| 6. | Carter, N. S., and Fairlamb, A. H. (1993) Nature 361, 173-175[CrossRef][Medline] [Order article via Infotrieve] |
| 7. |
de Koning, H.,
Watson, C. J.,
and Jarvis, S. M.
(1998)
J. Biol. Chem.
273,
9486-9494 |
| 8. | de Koning, H., and Jarvis, S. M. (1997) Eur. J. Biochem. 247, 1102-1110[Medline] [Order article via Infotrieve] |
| 9. | de Koning, H., and Jarvis, S. M. (1997) Mol. Biochem. Parasitol. 89, 245-258[CrossRef][Medline] [Order article via Infotrieve] |
| 10. | de Koning, H., and Jarvis, S. M. (1998) Biochem. Cell Biol. 76, 853-858[CrossRef][Medline] [Order article via Infotrieve] |
| 11. |
Carter, N. S.,
Berger, B. J.,
and Fairlamb, A. H.
(1995)
J. Biol. Chem.
270,
28153-28157 |
| 12. |
Sanchez, M. A.,
Ullman, B.,
Landfear, S. M.,
and Carter, N. S.
(1999)
J. Biol. Chem.
274,
30244-30249 |
| 13. | van Deursen, F. J., Shashi, S. K., Turner, C. M. R., Hartmann, C., Guerra-Giraldez, C., Matthews, K. R., and Clayton, C. E. (2001) Mol. Biochem. Parasitol. 112, 163-171[CrossRef][Medline] [Order article via Infotrieve] |
| 14. | Cunningham, I. (1977) J. Protozool. 24, 325-329[Medline] [Order article via Infotrieve] |
| 15. | Lanham, S. M., and Godfrey, D. G. (1970) Exp. Parasitol. 28, 521-534[CrossRef][Medline] [Order article via Infotrieve] |
| 16. | Sambrook, J., Fritsch, E. F., and Maniatis, T. (1989) Molecular Cloning: A Laboratory Manual , 2nd Ed. , Cold Spring Harbor Laboratory, Cold Spring Harbor, NY |
| 17. | Altschul, S. F., Gish, W., Miller, W., Myers, E. W., and Lippr, D. J. (1990) J. Mol. Biol. 215, 403-410[CrossRef][Medline] [Order article via Infotrieve] |
| 18. | Kozak, M. (1999) Gene (Amst.) 234, 187-208[CrossRef][Medline] [Order article via Infotrieve] |
| 19. |
Arriza, J. L.,
Kavanaugh, M. P.,
Fairman, W. A., Wu, Y.-N.,
Murdoch, G. H.,
North, R. A.,
and Amara, S. G.
(1993)
J. Biol. Chem.
268,
15329-15332 |
| 20. |
Langford, C. K.,
Little, B. M.,
Kavanaugh, M. P.,
and Landfear, S. M.
(1994)
J. Biol. Chem.
269,
17939-17943 |
| 21. |
Landfear, S. M.,
McMahon-Pratt, D.,
and Wirth, D. F.
(1983)
Mol. Cell. Biol.
3,
1070-1076 |
| 22. |
Seebeck, T.,
Whittaker, P. A.,
Imboden, M. A.,
Hardman, N.,
and Braun, R.
(1983)
Proc. Natl. Acad. Sci. U. S. A.
80,
4634-4638 |
| 23. |
Burchmore, R. J. S.,
and Landfear, S. M.
(1998)
J. Biol. Chem.
273,
29118-29126 |
| 24. | Bringaud, F., and Baltz, T. (1994) Mol. Biol. Evol. 11, 220-230[Abstract] |
| 25. |
Sundaram, M.,
Yao, S. Y. M.,
Ingram, J. C.,
Berry, Z. A.,
Adibi, F.,
Cass, C. E.,
Baldwin, S. A.,
and Young, J. D.
(2001)
J. Biol. Chem.
276,
45270-45275 |
| 26. |
Mäser, P.,
Süterlling, C.,
Kralli, A.,
and Kaminsky, R.
(1999)
Science
285,
242-244 |
| 27. | Griffiths, M., Yao, S. Y. M., Abidi, F., Phillips, S. E. V., Cass, C. E., Young, J. D., and Baldwin, S. A. (1997) Biochem. J. 328, 739-743 |
| 28. | Parker, M. D., Hyde, R. J., Yao, S. Y. M., McRobert, L., Cass, C. E., Young, J. D., McConkey, G. A., and Baldwin, S. A. (2000) Biochem. J. 349, 67-75[CrossRef][Medline] [Order article via Infotrieve] |
| 29. | Mastroberardino, L., Spindler, B., Pfeiffer, R., Skelly, P. J., Loffing, J., Shoemaker, C. B., and Verrey, F. (1998) Nature 395, 288-291[CrossRef][Medline] [Order article via Infotrieve] |
| 30. |
Vasudevan, G.,
Carter, N. S.,
Drew, M. E.,
Beverley, S. M.,
Sanchez, M. A.,
Seyfang, A.,
Ullman, B.,
and Landfear, B.
(1998)
Proc. Natl. Acad. Sci. U. S. A.
95,
9873-9878 |
| 31. |
Lin, R.,
Vera, J. C.,
Chaganti, R. S. K.,
and Golde, D. W.
(1998)
J. Biol. Chem.
273,
28959-28965 |
| 32. |
Devés, R.,
and Boyd, C. A. R.
(1998)
Physiol. Rev.
78,
487-545 |
This article has been cited by other articles:
![]() |
A. Luscher, P. Onal, A.-M. Schweingruber, and P. Maser Adenosine Kinase of Trypanosoma brucei and Its Role in Susceptibility to Adenosine Antimetabolites Antimicrob. Agents Chemother., November 1, 2007; 51(11): 3895 - 3901. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. I. Al-Salabi, L. J. M. Wallace, A. Luscher, P. Maser, D. Candlish, B. Rodenko, M. K. Gould, I. Jabeen, S. N. Ajith, and H. P. de Koning Molecular Interactions Underlying the Unusually High Adenosine Affinity of a Novel Trypanosoma brucei Nucleoside Transporter Mol. Pharmacol., March 1, 2007; 71(3): 921 - 929. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Geiser, A. Luscher, H. P. de Koning, T. Seebeck, and P. Maser Molecular Pharmacology of Adenosine Transport in Trypanosoma brucei: P1/P2 Revisited Mol. Pharmacol., September 1, 2005; 68(3): 589 - 595. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. L. Stewart, G. J. Bueno, A. Baliani, B. Klenke, R. Brun, J. M. Brock, I. H. Gilbert, and M. P. Barrett Trypanocidal Activity of Melamine-Based Nitroheterocycles Antimicrob. Agents Chemother., May 1, 2004; 48(5): 1733 - 1738. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. M. Landfear, B. Ullman, N. S. Carter, and M. A. Sanchez Nucleoside and Nucleobase Transporters in Parasitic Protozoa Eukaryot. Cell, April 1, 2004; 3(2): 245 - 254. [Full Text] [PDF] |
||||
![]() |
G. Cecchetto, S. Amillis, G. Diallinas, C. Scazzocchio, and C. Drevet The AzgA Purine Transporter of Aspergillus nidulans: CHARACTERIZATION OF A PROTEIN BELONGING TO A NEW PHYLOGENETIC CLUSTER J. Biol. Chem., January 30, 2004; 279(5): 3132 - 3141. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. E. Drew, J. C. Morris, Z. Wang, L. Wells, M. Sanchez, S. M. Landfear, and P. T. Englund The Adenosine Analog Tubercidin Inhibits Glycolysis in Trypanosoma brucei as Revealed by an RNA Interference Library J. Biol. Chem., November 21, 2003; 278(47): 46596 - 46600. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Matovu, M. L. Stewart, F. Geiser, R. Brun, P. Maser, L. J. M. Wallace, R. J. Burchmore, J. C. K. Enyaru, M. P. Barrett, R. Kaminsky, et al. Mechanisms of Arsenical and Diamidine Uptake and Resistance in Trypanosoma brucei Eukaryot. Cell, October 1, 2003; 2(5): 1003 - 1008. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. J. S. Burchmore, L. J. M. Wallace, D. Candlish, M. I. Al-Salabi, P. R. Beal, M. P. Barrett, S. A. Baldwin, and H. P. de Koning Cloning, Heterologous Expression, and in Situ Characterization of the First High Affinity Nucleobase Transporter from a Protozoan J. Biol. Chem., June 20, 2003; 278(26): 23502 - 23507. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Acimovic and I. R. Coe Molecular Evolution of the Equilibrative Nucleoside Transporter Family: Identification of Novel Family Members in Prokaryotes and Eukaryotes Mol. Biol. Evol., December 1, 2002; 19(12): 2199 - 2210. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Sankar, J. Machado, P. Abdulla, A. J. Hilliker, and I. R. Coe Comparative genomic analysis of equilibrative nucleoside transporters suggests conserved protein structure despite limited sequence identity Nucleic Acids Res., October 15, 2002; 30(20): 4339 - 4350. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP |